creos™ – Celebrating a decade of excellence in regenerative solutions

In the ever-evolving world of dental regenerative solutions, Nobel Biocare has consistently set the benchmark for innovation and quality. As we celebrate the 10th anniversary of the creos brand, it’s an opportune moment to reflect on a decade of milestones, exceptional products, and strategic acquisitions that have solidified Nobel Biocare’s position as a premium manufacturer and a leader in the regenerative market.

A decade of innovation and excellence

Since its unveiling at the Academy of Osseointegration Annual Meeting in 2014, the creos brand has been synonymous with quality, reliability, and outstanding clinical outcomes. Over the past decade, the creos portfolio has evolved to become a leader in dental regeneration, offering more than just premium bone grafts and membrane but a whole portfolio of products including sutures, screws, wound dressings and much more. Today, with over 20 products, 3 in-house manufacturing sites, and numerous clinical studies, the continuously expanding creos product portfolio is just as dedicated to providing premium regenerative solutions as its first day in 2014.

creos™ xenoprotect and beyond

One of the shining stars in the creos portfolio is creos xenoprotect, a resorbable collagen membrane that has set new standards in regeneration. With over 16 published clinical cases, by renowned GBR and GTR specialists like Drs. Bastian Wessing and Arturo Llobell, creos xenoprotect stands out due to its exceptional handling properties, predictable resorption profile, and reliable performance in a variety of clinical situations. Its unique composition and advanced manufacturing process ensure optimal outcomes, making it a preferred choice for dentists and surgeons aiming for predictable and successful regenerative procedures.

This year, creos xenoprotect reached a monumental milestone, with the sale of its one millionth unit. Reaching the one millionth milestone is a testament to the trust and confidence that the dental community has placed in creos xenoprotect. It reflects Nobel Biocare’s commitment to predictability and delivering superior products that meet the evolving needs of dental professionals and their patients.

With the introduction of creos xenogain and creos xenogain collagen in 2016, the regenerative portfolio gained momentum in other categories beyond membranes. A wide range of products continued to be developed through the next several years, including premium xenogenic bone grafts, a variety of wound dressings, sutures and membrane fixation kits. From the very first creos xenoprotect to the 1 millionth, all the way down to every bone graft granule, the creos portfolio carries the Nobel Biocare legacy proudly into the future of regeneration.

Strategic acquisitions: expanding horizons

Nobel Biocare's journey towards becoming the leader in the regenerative market is marked by strategic acquisitions that have empowered Nobel Biocare's product portfolio and expertise in the areas of research and development, biomaterials, manufacturing, stringent quality control, and customer delivery.

– Matricel: Known for its cutting-edge biomaterial solutions, especially on resorbable collagen membranes and collagen matrix, Matricel’s integration into Nobel Biocare has enhanced the company’s capabilities in developing advanced regenerative products that are both innovative and predictable.

– Osteogenics: With a strong reputation in the field of dPTFE membrane (Cytoplast®), Osteogenics’ acquisition has bolstered Nobel Biocare’s portfolio, allowing the company to offer an unmatched comprehensive range of regenerative solutions to meet diverse clinical needs.

– Mimetis: A pioneer in the field of synthetic bone graft substitutes, Mimetis has brought valuable expertise and technology to Nobel Biocare, further strengthening its position as a leader in dental regeneration.

These strategic acquisitions demonstrate Nobel Biocare’s unwavering commitment to expanding its regenerative product offerings and solidifying its leadership in the market. By incorporating the strengths and innovations of these companies, Nobel Biocare continues to push the boundaries of what is possible in dental regeneration.

Looking forward: the future of regenerative solutions

As Nobel Biocare celebrates the 10th anniversary of the creos brand, the company remains dedicated to advancing the field of dental regeneration. The continuous investment in research and development, coupled with the integration of new technologies and materials, ensures that Nobel Biocare will continue to provide cutting-edge solutions that set new industry standards.

Here’s to a decade of transformative advancements and to many more years of pioneering excellence in dental regeneration. Happy 10th anniversary, creos!

Not all products described here are available in all markets. Contact your local sales representative to learn more about the solutions available in your area.